Earnings Summary

Apollo Medical Holdings Inc’s revenue jumped 29.11% since last year same period to $348.21Mn in the Q2 2023. On a quarterly growth basis, Apollo Medical Holdings Inc has generated 3.25% jump in its revenue since last 3-months.

Apollo Medical Holdings Inc’s net profit jumped 15.54% since last year same period to $13.17Mn in the Q2 2023. On a quarterly growth basis, Apollo Medical Holdings Inc has generated -9.93% fall in its net profits since last 3-months.

Apollo Medical Holdings Inc’s net profit margin fell -10.51% since last year same period to 3.78% in the Q2 2023. On a quarterly growth basis, Apollo Medical Holdings Inc has generated -12.77% fall in its net profit margins since last 3-months.

Apollo Medical Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a -84.38% fall from last quarter’s estimates.

Apollo Medical Holdings Inc’s earning per share (EPS) estimates for the current year stand at 0.05.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Apollo Medical Holdings Inc’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Apollo Medical Holdings Inc’s return on equity (ROE) stands at 0.1.